Phase 1-2 MAHCT w/ TCell Depleted Graft w/ Simultaneous Infusion Conventional and Regulatory T Cell

Clinical trial NCT01660607 · COMPLETED

Trial details

NCT number: NCT01660607
Sponsor: Stanford University
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Myeloid Leukemia, Chronic Acute Myelogenous Leukemia Myelodysplastic Syndromes (MDS)Lymphoma, Non-Hodgkin Acute Lymphoblastic Leukemia (ALL)Myeloproliferative Syndrome Acute Myeloid Leukemia Acute Leukemia Chronic Myelogenous Leukemia

Start date: 2012-02-09
Primary completion: 2023-12-20
Enrollment: 68

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.